Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06511232 · ClinicalTrials.gov registry record · Phase 4
Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction
A Phase 4 study of Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Tear, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT06511232 is a Phase 4 study of Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Tear that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 84 participants, below the 320-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06511232, a Phase 4 study of Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Tear, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.
Conditions Studied
Interventions
- DRUG Intraosseous Morphine
Study Locations (1)
Texas
- Houston Methodist Research Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2029-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06511232
The ClinicalTrials.gov registry entry for NCT06511232 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 320-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (74% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Anterior Cruciate Ligament Injuries appearing as the primary indexed condition, and to 1 intervention - of which Intraosseous Morphine is the first listed.
NCT06511232 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06511232 about?
NCT06511232 is a clinical study titled "Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction". The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.
What is the current status of trial NCT06511232?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2024-08-19. Estimated completion is 2029-07-31.
What conditions does trial NCT06511232 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Tear, Anterior Cruciate Ligament Rupture.
What interventions are being tested in trial NCT06511232?
The interventions under investigation include: Intraosseous Morphine (DRUG).
Who is sponsoring clinical trial NCT06511232?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06511232 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction
RECRUITING · Phase 4
-
Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
COMPLETED · Phase 4
-
Anterior Cruciate Ligament Recovery With Virtual Psychological Intervention
RECRUITING · NA
-
Steps Towards Osteoarthritis Prevention
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
Explore more on PlainTrial
Anterior Cruciate Ligament Injuries
All registered trials for this condition
Anterior Cruciate Ligament Tear
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.